Anand Bagaria, senior research analyst, Finquest explains to CNBC-TV18 that pharma major Wockhardt has posted a strong run in terms of a stock performance as well as fundamentals and gained over 250% from the start of the year.
first published: Aug 7, 2012 03:22 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

